T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.62B |
| 2 |
Ingersoll Rand
IR
|
+$2.99B |
| 3 |
Fortive
FTV
|
+$2.58B |
| 4 |
Apple
AAPL
|
+$2.46B |
| 5 |
Yum! Brands
YUM
|
+$2.1B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Healthcare | 21.85% |
| 3 | Financials | 13.14% |
| 4 | Consumer Discretionary | 12.07% |
| 5 | Industrials | 11.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Zentalis Pharmaceuticals
ZNTL
$307M
| $47.8M | 0.04% |
+2,208,669
| New | +$60.4M |
|
|
SAFE
352
DELISTED
Safehold Inc.
SAFE
| $47.6M | 0.04% |
+1,798,513
| New | +$70.1M |
|
353
Encore Capital Group
ECPG
$2.14B
| $47.4M | 0.04% |
+1,043,143
| New | +$60M |
|
354
Essent Group
ESNT
$6.15B
| $47.4M | 0.04% |
+1,359,893
| New | +$54.5M |
|
355
AtriCure
ATRC
$2.22B
| $47.2M | 0.04% |
+1,206,646
| New | +$55.2M |
|
356
Bumble
BMBL
$348M
| $47M | 0.04% |
+2,184,807
| New | +$64.6M |
|
|
CIR
357
DELISTED
CIRCOR International, Inc
CIR
| $46.6M | 0.04% |
+2,826,023
| New | +$47M |
|
358
MaxLinear
MXL
$7.03B
| $46M | 0.04% |
+1,408,630
| New | +$52.1M |
|
|
RNAM
359
DELISTED
Avidity Biosciences
RNAM
| $45.3M | 0.04% |
+2,775,292
| New | +$53.1M |
|
360
International Seaways
INSW
$4.7B
| $44.1M | 0.04% |
+1,256,043
| New | +$34.8M |
|
361
Pacific Biosciences
PACB
$351M
| $44M | 0.04% |
+7,572,558
| New | +$43.4M |
|
|
VMEO
362
DELISTED
Vimeo
VMEO
| $43.5M | 0.03% |
+10,871,510
| New | +$64.3M |
|
363
Kymera Therapeutics
KYMR
$9.52B
| $43.5M | 0.03% |
+1,996,529
| New | +$52.6M |
|
|
VERV
364
DELISTED
Verve Therapeutics
VERV
| $43.1M | 0.03% |
+1,254,816
| New | +$40M |
|
|
BSKYU
365
DELISTED
Big Sky Growth Partners, Inc. Unit
BSKYU
| $43M | 0.03% |
+4,402,944
| New | +$43.2M |
|
366
Pennant Group
PNTG
$1.36B
| $42.8M | 0.03% |
+4,112,113
| New | +$58.8M |
|
|
AMK
367
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $42.6M | 0.03% |
+2,328,552
| New | +$45.1M |
|
|
CPAAU
368
DELISTED
Conyers Park III Acquisition Corp. Unit
CPAAU
| $42.2M | 0.03% |
+4,320,042
| New | +$42.6M |
|
|
PRA
369
DELISTED
ProAssurance
PRA
| $42M | 0.03% |
+2,153,099
| New | +$47.3M |
|
370
Equity Bancshares
EQBK
$1.06B
| $40.7M | 0.03% |
+1,372,708
| New | +$42.4M |
|
371
Relay Therapeutics
RLAY
$4.45B
| $40.5M | 0.03% |
+1,811,603
| New | +$39.8M |
|
|
COUP
372
DELISTED
Coupa Software Incorporated
COUP
| $40.5M | 0.03% |
+688,537
| New | +$45.1M |
|
373
Five Star Bancorp
FSBC
$1.16B
| $40.1M | 0.03% |
+1,413,548
| New | +$37.1M |
|
374
Ranger Energy Services
RNGR
$402M
| $40M | 0.03% |
+4,094,978
| New | +$38.6M |
|
|
RPC
375
Ridgepost Capital
RPC
$983M
| $39.7M | 0.03% |
+3,771,662
| New | +$45M |
|
Similar funds
T. Rowe Price Investment Management's Q3 2022 Portfolio in Review
Q3 2022 is the first quarter with a 13F filing on record for T. Rowe Price Investment Management, which disclosed 541 positions worth $125B. Its ten largest holdings account for 18% of the portfolio.
Its largest position is Microsoft: 17,509,233 shares worth $4.08B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, followed by Healthcare and Financials.
- T. Rowe Price Investment Management's largest Q3 2022 buy was Microsoft: 17,509,233 shares worth $4.08B.
- T. Rowe Price Investment Management's ten largest holdings make up 18% of its $125B portfolio in Q3 2022.
- T. Rowe Price Investment Management disclosed 541 positions in Q3 2022, its first 13F filing on record.
Based on T. Rowe Price Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.